| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Biotoxtech Co. Ltd. is a preeminent non-clinical contract research organization (CRO) based in South Korea, dedicated to the safety evaluation of diverse products ranging from pharmaceuticals to biotechnological products. Founded in the year 2000 and with its headquarters in Cheongju, Biotoxtech has established itself as a critical player in the life sciences sector. The organization specializes in conducting comprehensive toxicological assessments to ensure the safety and regulatory compliance of products before they enter the market. With its state-of-the-art facilities and a detailed approach to testing, Biotoxtech caters to the stringent needs of industries such as pharmaceuticals, biotechnology, agrochemicals, and food, facilitating the safe and effective development of new compounds. As a crucial component of the product development and regulatory approval process, Biotoxtech significantly impacts the health and agricultural sectors, offering indispensable data that guide product development decisions, regulatory submissions, and market entry strategies.
Biotoxtech specializes in thorough toxicology testing to evaluate the safety of pharmaceuticals, chemicals, and biotechnological products. This service ensures that clients’ products meet necessary safety standards for regulatory approval. Through animal testing and mechanistic studies, the company identifies potential toxic effects and assesses the safety and efficacy of new compounds.
The company prides itself on its advanced testing facilities that enable the handling of complex testing procedures with precision. These facilities are equipped to support studies across a wide range of products, facilitating detailed analyses that contribute significantly to the product development process.
Across various industries such as pharmaceuticals, biotechnology, agrochemicals, and food, Biotoxtech offers targeted solutions to meet the specific needs of its clients. These services are designed to navigate the unique regulatory and safety evaluation challenges present in each sector, providing tailored support that ensures the successful development and approval of products.
Biotoxtech plays a pivotal role in assisting companies with the preparation of regulatory submissions and the formulation of effective market entry strategies. By providing critical data and analyses required for product approval, Biotoxtech helps clients navigate the complex regulatory landscape and achieve successful product launches.